Morse Asset Management, Inc Horizon Therapeutics Public LTD CO Transaction History

Morse Asset Management, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$79.4 - $116.36 $88,531 - $129,741	-1,115 Reduced 8.58%	11,885 $948,000
Q1 2022 May 12, 2022	SELL	$86.42 - $109.81 $1.67 Million - $2.13 Million	-19,370 Reduced 59.84%	13,000 $1.37 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $658,380 - $800,998	-6,680 Reduced 17.11%	32,370 $3.49 Million
Q3 2021 Nov 09, 2021	BUY	$91.91 - $110.37 $620,392 - $744,997	6,750 Added 20.9%	39,050 $4.28 Million
Q2 2021 Aug 13, 2021	BUY	$86.24 - $95.92 $1.28 Million - $1.43 Million	14,900 Added 85.63%	32,300 $3.03 Million
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $821,376 - $1.09 Million	11,435 Added 191.7%	17,400 $1.6 Million
Q4 2020 Feb 11, 2021	BUY	$67.0 - $84.39 $191,955 - $241,777	2,865 Added 92.42%	5,965 $436,000
Q3 2020 Nov 09, 2020	BUY	$55.23 - $79.93 $171,213 - $247,783	3,100 New	3,100 $241,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Morse Asset Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Morse Asset Management, Inc with notifications on news.